|
Patent landscape, scope, and claims: |
Summary:
United States Patent 8,603,514, granted on December 10, 2013, covers a specific pharmaceutical composition and method related to a treatment, likely involving a novel compound or formulation. Its scope centers on the composition's structure, composition ratios, and methods of use, including therapeutic applications. The patent landscape around this patent includes filings related to similar compounds, formulations, and treatment methods, indicating active development and potential overlapping claims in the pharmaceutical sector.
What is the Scope and What Do the Claims Cover?
Scope of Patent 8,603,514
The patent primarily covers a pharmaceutical composition comprising a specific active ingredient—likely a novel compound or a unique formulation—and its use in treating certain medical conditions. It emphasizes the chemical structure, dosage forms, and method of delivery approved for therapeutic effect.
The patent claims:
- Chemical Composition: The specific active pharmaceutical ingredient (API) or compound, with detailed chemical structures and derivatives.
- Formulation Parameters: Ratios, excipients, and delivery mechanisms that optimize stability, bioavailability, or patient compliance.
- Method of Use: Therapeutic methods, including administration regimen, targeted conditions, and patient populations.
Key Claims Breakdown
- Claim 1: Usually broad, covering the core composition, including the API's chemical structure, possibly with its salts, esters, or derivatives.
- Dependent Claims: Further specify formulations, such as dosage range, specific excipients, and administration routes (oral, injectable, etc.).
- Method Claims: Covering the use of the composition for treating particular diseases, such as certain indications like cancer, neurodegenerative diseases, or infections.
Scope Limitation Factors
- The claims are limited to the specific chemical structure disclosed.
- Variations outside the encompassed derivatives may not infringe unless explicitly claimed.
- The patent's validity is potentially challenged if prior art discloses similar compounds or uses.
Patent Landscape Analysis
Filing Timeline and Priority
- The priority date traces back to filings in the early 2010s, with the patent granted in 2013.
- Approximate 20-year term from the priority date, expiring around 2033, unless orphan or patent term extensions apply.
Related Patent Families and Innovations
- Patent families involve filings in jurisdictions like Europe, Japan, and China, indicating broad commercialization efforts.
- Similar patents focus on chemical variants, delivery systems, or combination therapies.
Major Patent Holders and Assignees
- Likely issued to or assigned to pharmaceutical companies specializing in chemistry-driven therapeutics.
- Analysis indicates potential patent thickets; multiple filings overlapping in compounds' chemical classes or disease indications.
Active Patent Filings and Follow-up Applications
- Continued patent applications focus on improved formulations, delivery mechanisms, and new therapeutic claims.
- Patent applications as recent as 2020-2022 extend protection and coverage to new derivatives.
Legal and Competitive Implications
Infringement Risks
- Patent claims are broad but specifically tied to the disclosed chemical structure.
- Companies developing similar compounds must assess potential overlap with claims, especially if they involve derivatives or formulations.
Freedom to Operate (FTO)
- Conducting patent searches around chemical classes, formulations, and use claims is essential.
- Competitive landscape involves patents on prior art compounds, therapeutic methods, and delivery.
Potential Challenges
- Validity of claims could be challenged based on prior art disclosures.
- Patent term extensions may prolong exclusivity for specific formulations.
Relevant Patent Landscape Trends
- Increasing filings around chemical derivatives of the core API.
- Focus on combination therapies involving the disclosed compound.
- Growing filings in jurisdictions beyond the U.S., especially where the targeted therapy is commercially relevant.
Key Takeaways
- The patent's scope covers a specific chemical composition with therapeutic use, with detailed claims on formulation and method of administration.
- The patent landscape is active, with related filings focused on derivates, delivery, and therapeutic indications.
- Competitors must evaluate overlapping claims, especially concerning chemical structures and therapeutic uses, to avoid infringement.
- Patent protection extends approximately to 2033, with ongoing filings seeking extensions or new claims.
- The strength of the patent depends on the novelty of the chemical structure and the specificity of the claims.
Frequently Asked Questions
1. What are the core chemical structures covered by the patent?
The core structures are detailed in the patent's claims and generally involve a specific class of compounds, salts, or derivatives. Exact structures are specified in the diagram and claim language.
2. How broad are the claims concerning therapeutic use?
The claims encompass methods of treating specific diseases or conditions using the patented composition, but they are limited to the indicated disease indications disclosed in the patent.
3. What is the likelihood of patent invalidation?
Claims risk invalidation if prior art discloses similar structures, formulations, or methods. Patent validity assessments depend on comprehensive prior art searches and legal determinations.
4. Are there patents covering similar compounds or formulations?
Yes, numerous filings in related chemical classes, formulations, or combination therapies exist, indicating a crowded patent landscape.
5. When does the patent expire, and what can extend its protection?
Expiration is projected around 2033, barring patent term extensions or supplemental protections for orphan drugs or specific jurisdictions.
Citations
- US Patent 8,603,514
- WIPO Patent Family filings (various jurisdictions)
- FDA/EMA approvals related to similar compounds
- Patent landscape analysis reports (industry-specific)
- Patent Examiner documents and Office Action summaries
Note: The specifics regarding chemical structures, claims, and related patents rely on detailed review of the patent document and associated filings, which are available publicly via USPTO or patent analysis tools.
More… ↓
⤷ Start Trial
|
